Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine nasal spray for acute pain after CT-guided lung nodule localization
ChiCTR2200061734Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Shanghai Chest Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in acute pain (3 arms), sponsored by Department of Anesthesiology, Shanghai Chest Hospital. Primary endpoint: Pain remission rate. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2200061734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061734.